Siemens Medical Solutions of Malvern, PA, has received U.S. Food and Drug Administration (FDA) clearance for its Versant 440 molecular system for use with Versant HCV RNA 3.0 assay for the management of patients with the hepatitis C virus (HCV) who are undergoing antiviral therapy.
Siemens' system for automated viral load testing is designed to enhance throughput and maximize productivity in clinical laboratories.
Related Reading
Siemens gets FDA OK for zeego, partners with AFRL February 18, 2008
Siemens responds to FDA warning letter, February 15, 2008
Siemens forms Colorado R&D deal, February 13, 2008
Siemens installs first Essenza scanner, February 11, 2008
Siemens receives CCHIT OK for Invision, February 1, 2008
Copyright © 2008 AuntMinnie.com
